SEC Tracker
Get the app

aTYR PHARMA ATYR

aTYR PHARMA: makes a Regulation FD disclosure

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
Exhibit 99.1
Press release
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when aTYR PHARMA files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Maze Therapeutics MAZE public float $444M, Jun 30, 2025
  2. Cullinan Therapeutics CGEM public float $442M, Jun 30, 2025
  3. MeiraGTx Holdings MGTX public float $525M, Jun 30, 2025
  4. Iovance Biotherapeutics IOVA public float $535M, Jun 30, 2025
  5. REGENXBIO RGNX public float $385M, Jun 30, 2025